DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens

Anton M. Lakstygal, Tatiana O. Kolesnikova, Sergey L. Khatsko, Konstantin N. Zabegalov, Andrey D. Volgin, Konstantin A. Demin, Vadim A. Shevyrin, Edina A. Wappler-Guzzetta, Allan V. Kalueff

Research output

4 Citations (Scopus)

Abstract

Anticholinergic drugs based on tropane alkaloids, including atropine, scopolamine, and hyoscyamine, have been used for various medicinal and toxic purposes for millennia. These drugs are competitive antagonists of acetylcholine muscarinic (M-) receptors that potently modulate the central nervous system (CNS). Currently used clinically to treat vomiting, nausea, and bradycardia, as well as alongside other anesthetics to avoid vagal inhibition, these drugs also evoke potent psychotropic effects, including characteristic delirium-like states with hallucinations, altered mood, and cognitive deficits. Given the growing clinical importance of anti-M deliriant hallucinogens, here we discuss their use and abuse, clinical importance, and the growing value in preclinical (experimental) animal models relevant to modeling CNS functions and dysfunctions.

Original languageEnglish
Pages (from-to)2144-2159
Number of pages16
JournalACS Chemical Neuroscience
Volume10
Issue number5
DOIs
Publication statusPublished - 15 May 2019

    Fingerprint

Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this